Clinical Trials
15 trialsNCT06260150 2024-02-15
Application of IPC During Surgery to Prevent Venous Thrombosis in Gastrointestinal Surgery Patients.
Shandong Provincial Hospital
Phase NA Unknown
NCT05517408 2023-08-16
Dose Exploration of Ciprofol for Sedation in Gastrointestinal Endoscopic Diagnosis and Treatment of Obese Patients.
RenJi Hospital
Phase NA Unknown
NCT02633098 2022-10-12
NeoART
St George's, University of London
Phase 2 Unknown
NCT05526339 2022-09-02
HFNO Combined With NPA Reduces Hypoxia During Sedated Gastrointestinal Endoscopy In Obese Patients
RenJi Hospital
Phase NA Unknown
NCT05510388 2022-08-22
HRISK
RenJi Hospital
Phase NA Unknown
NCT05193292 2022-01-14
Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal Cancer
Fudan University
Phase 2 Unknown
NCT03563586 2020-09-11
MECCA
National and Kapodistrian University of Athens
Phase NA Unknown
NCT03271255 2019-01-23
Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)
Shenzhen People's Hospital
Phase 2 Unknown
NCT01037049 2018-09-17
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks
Royal Marsden NHS Foundation Trust
Phase 2 Unknown
NCT03303495 2017-10-06
A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC
Sun Yat-sen University
Phase 3 Unknown
NCT03280407 2017-09-28
NEOLAR
Zealand University Hospital
Phase 2 Unknown
NCT02662348 2016-01-25
T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System
The First Affiliated Hospital with Nanjing Medical University
Phase 1 Unknown
NCT02202928 2015-12-28
Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer
Shenzhen Hornetcorn Bio-technology Company, LTD
Phase 2 Unknown
NCT02552017 2015-09-16
ADENOMA
South Tyneside and Sunderland NHS Foundation Trust
Phase NA Unknown
NCT01549418 2012-03-09
ASAPOL
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 4 Unknown